Related Experiment Video
Updated: Jun 7, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
Diabetic Ketoacidosis: Evaluation and Treatment
Brian Veauthier1, Blaine Levy-Grau1
1University of Wyoming Family Medicine Residency Program, Casper.
American Family Physician
|November 18, 2024
Summary
Diabetic ketoacidosis (DKA) is a serious diabetes complication. Diagnosis now de-emphasizes hyperglycemia due to euglycemic DKA, while treatment focuses on fluids, insulin, and addressing causes.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Diabetes Management
Background:
- Diabetic ketoacidosis (DKA) is a severe complication of diabetes mellitus, stemming from insulin deficiency.
- It affects patients of all ages and can be the first sign of diabetes, particularly in children.
- Common symptoms include increased thirst and urination, nausea, vomiting, and fatigue.
Purpose of the Study:
- To review the diagnostic criteria, precipitating factors, and management strategies for diabetic ketoacidosis.
- To highlight the evolving diagnostic landscape, including the recognition of euglycemic DKA.
- To outline essential laboratory evaluations and treatment protocols for DKA.
Main Methods:
- Review of current literature and clinical guidelines on DKA diagnosis and management.
- Analysis of diagnostic criteria, including the role of hyperglycemia, acidosis, and ketones.
- Examination of laboratory tests and imaging for DKA evaluation.
- Summary of treatment principles: fluid and electrolyte replacement, insulin therapy, and management of precipitating factors.
Main Results:
- Traditional DKA diagnosis involves hyperglycemia, acidosis, and ketones, but hyperglycemia is de-emphasized due to euglycemic DKA.
- Sodium-glucose cotransporter-2 inhibitors are associated with a modest increase in DKA risk, including euglycemic DKA.
- Comprehensive laboratory evaluation is crucial for identifying DKA causes and complications.
Conclusions:
- DKA management requires prompt fluid and electrolyte repletion, insulin administration, and treatment of underlying causes.
- Prevention strategies involve early diabetes detection, patient education, and consistent access to diabetes therapies.
- Ongoing monitoring is essential for adjusting therapy and managing DKA complications effectively.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
236
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
236
Diabetes: Symptoms, Diagnosis, and Complications
508
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
508
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Hypoglycemia and Glucagon
152
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
152
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Acute Pancreatitis II: Clinical Manifestations and Management
93
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
93

